InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
T+90 hit rate
20%
T+90 mean return
+12.0%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by McCarthy Sean A., Chief Executive Officer. Insider active across 1 company, notably CytomX Therapeutics, Inc.. Cumulatively, 24 reports have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €1.3m. Activity tracked since 30 September 2019. The latest transaction was filed on 18 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations24 total
37,656 shares@ US$0.5991.2% of flowCommon StockSEC:0001610717-25-000086:0
180,000 shares0Common StockSEC:0001610717-25-000016:0
37,500 shares0Common StockSEC:0001610717-24-000432:0
109,768 shares@ US$1.57499.5% of flowCommon StockSEC:0001610717-24-000190:0
20,223 shares@ US$2.08552.3% of flowCommon StockSEC:0001610717-24-000178:0
90,000 shares0Common StockSEC:0001610717-24-000036:0
13,551 shares@ US$1.38071.0% of flowCommon StockSEC:0001610717-23-000423:0
37,500 shares0Common StockSEC:0001610717-23-000411:0
40,000 shares0Common StockSEC:0001610717-23-000297:0
16,535 shares@ US$1.57491.4% of flowCommon StockSEC:0001610717-23-000061:0
7,121 shares@ US$1.88050.8% of flowCommon StockSEC:0001140361-23-012618:0
105,000 shares0Common StockSEC:0001567619-23-001930:0
40,000 shares0Common StockSEC:0001567619-22-014299:0
66,742 shares@ US$0.9450.0082% mcap4.2% of flowCommon StockSEC:0001567619-22-010091:0
75,000 shares0Common StockSEC:0001567619-22-002521:0
75,000 shares0Common StockSEC:0001567619-22-002521
92,113 shares@ US$1.13390.012% mcap6.3% of flowCommon StockSEC:0001567619-21-015554:0
92,113 shares@ US$1.13395.3% of flowCommon StockSEC:0001567619-21-015554
100,000 shares@ US$7.044734.9% of flowCommon StockSEC:0001567619-21-012419
100,000 shares@ US$7.04470.081% mcap41.6% of flowCommon StockSEC:0001567619-21-012419:0
30 shares@ US$1.13390.0% of flowCommon StockSEC:0001567619-21-012252
30 shares@ US$1.13390.0000% mcap0.0% of flowCommon StockSEC:0001567619-21-012252:0
4,500 shares0Common StockSEC:0001567619-21-011808:0
4,500 shares0Common StockSEC:0001567619-21-011808
24 of 24 declarations
About McCarthy Sean A.
McCarthy Sean A. serves as President and CEO at CytomX Therapeutics, Inc. He is responsible for the strategic direction of the company and overseeing operations. His role is essential in ensuring the growth and performance of the company in the biopharmaceutical sector.
